相关实验视频
Updated: Jun 25, 2025

07:33
Noninvasive, High-throughput Determination of Sleep Duration in Rodents
Published on: April 18, 2018
7.8K
SGLT2抑制,循环蛋白和失眠:一个门德尔的随机化研究
Jinlan Luo1, Ling Tu1, Chenchen Zhou2
1Department of Geriatric Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China; Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, 430030, China.
Sleep medicine
|May 25, 2024
概括
-葡萄糖共运输体2抑制剂 (SGLT2i) 降低失眠风险,增加睡眠时间. 血二腺四酸酶 (Ap4A) 可能会调解这种效应,这表明睡眠障碍是一种新的治疗点.
科学领域:
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
- 睡眠医学 睡眠医学
背景情况:
- -葡萄糖共运输体2抑制剂 (SGLT2i) 主要是口服抗糖尿病药物,具有已知的性作用.
- 失眠是一种广泛且具有影响力的睡眠障碍,与SGLT2i的联系尚不清楚.
- 这项研究调查了SGLT2抑制剂和失眠之间的因果关系.
研究的目的:
- 确定SGLT2抑制对失眠和睡眠时间的因果作用.
- 为了确定循环中的蛋白质,调解SGLT2抑制和失眠之间的关系.
- 探索SGLT2抑制驱动的血蛋白在引起失眠中的作用.
主要方法:
- 进行了两样本的门德尔随机化 (MR) 分析,以评估SGLT2抑制对失眠和睡眠持续时间的因果关系.
- 一个两步和全蛋白质组的MR分析调查了SGLT2抑制和4907个循环蛋白之间的因果关系.
- 调解分析确定了调解SGLT2抑制对失眠的影响的血蛋白,并应用了FDR校正.
主要成果:
- 抑制SGLT2与失眠有显著的负相关性 (OR=0.791,P=5.579*10^-6),与睡眠时间有积极相关性 (β=0.186,P=0.004).
- 确定了二亚丁四酸酶 (Ap4A) 是一种与SGLT2抑制和失眠相关的血蛋白.
- 调解分析显示,Ap4A部分调解SGLT2抑制对失眠的影响 (β=-0.018,P=0.023),占该效应的7.7%.
结论:
- 这项研究确定了SGLT2抑制与降低失眠风险之间的因果关系.
- 血Ap4A被确定为SGLT2抑制剂与失眠之间的关系中的潜在调解者.
- 这些发现表明,SGLT2抑制剂可能通过Ap4A调节为失眠提供治疗效益.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
248
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
248
Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K

